期刊
ONCOIMMUNOLOGY
卷 2, 期 8, 页码 -出版社
LANDES BIOSCIENCE
DOI: 10.4161/onci.25218
关键词
melanoma; BRAF; vemurafenib; myeloid-derived suppressor cells; moMDSC; grMDSC
Myeloid-derived suppressor cells (MDSC) potently repress antitumor immunity. the amount of MDSC in the blood of melanoma patients declines in response to vemurafenib, an inhibitor of oncogenic BRAF signaling that abrogates the ability of malignant cells to induce MDSC. this suggests that vemurafenib may be used in combination with various immunotherapeutic agents for the induction of long-lasting tumor regression.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据